Direct to consumer advertising in healthcare: History, benefits, and concerns

Clinical Orthopaedics and Related Research

Volumn 457, Issue , 2007, Pages 96-104

  Adeoye, Sanjo ^a   Bozic, Kevin J ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERTIZING; CONFERENCE PAPER; CONSUMER; DOCTOR PATIENT RELATION; FOOD AND DRUG ADMINISTRATION; HEALTH CARE DELIVERY; HOSPITAL CARE; PATIENT EDUCATION; PHYSICIAN; PRIORITY JOURNAL; TREATMENT PLANNING; WELLBEING; ATTITUDE TO HEALTH; ECONOMICS; ETHICS; HEALTH CARE COST; HUMAN; INFORMATION DISSEMINATION; METHODOLOGY; ORTHOPEDICS; REVIEW; STATISTICS;

ADVERTISING; CONSUMER PARTICIPATION; HEALTH CARE SECTOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFORMATION DISSEMINATION; ORTHOPEDICS; PATIENT EDUCATION;

EID: 34147107534     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/BLO.0b013e31803427e6     Document Type: Conference Paper

References (35)

1. Aikin KJ, Swasy JL, Braman AC. Patient and Physician Attitudes and Behaviors Associated with DTC Promotion of Presciption Drugs - Summary of FDA Survey Research Results. Rockville, MD: Center for Drug Evaluation and Research, Food Drug Administration, US Dept of Health and Human Services; 2004.
2. Becker C. Skipping the hospital: implant campaign goes straight to the patient. Mod Healthc. 2003;33:16.
3. Bell RA, Kravitz RL, Wilkes MS. Direct-to-consumer prescription drug advertising and the public. J Gen Intern Med. 1999;14:651-657.
4. Bell RA, Kravitz RL, Wilkes MS. Direct-to-consumer prescription drug advertising, 1989-1998: a content analysis of conditions, targets, inducements, and appeals. J Fam Pract. 2000;49:329-335.
5. Bell RA, Wilkes MS, Kravitz RL. Advertisement-induced prescription drug requests: patients' anticipated reactions to a physician who refuses. J Fam Pract. 1999;48:446-452.
6. Bhattacharyya T, Tornetta P 3rd, Healy WL, Einhorn TA. The validity of claims made in orthopaedic print advertisements. J Bone Joint Surg Am. 2003;85:1224-1228.
7. Callaghan JJ, Crowninshield RD, Greenwald AS, Lieberman JR, Rosenberg AG, Lewallen DG. Symposium: introducing technology into orthopaedic practice: how should it be done? J Bone Joint Surg Am. 2005;87:1146-1158.
8. Donohue JM, Berndt ER, Rosenthal M, Epstein AM, Frank RG. Effects of pharmaceutical promotion on adherence to the treatment guidelines for depression. Med Care. 2004;42:1176-1185.
9. Findlay SD. Direct-to-consumer promotion of prescription drugs: economic implications for patients, payers and providers. Pharmacoeconomics. 2001;19:109-119.
10. Gahart MT, Duhamel LM, Dievler A, Price R. Examining the FDA's oversight of direct-to-consumer advertising. Health Aff (Millwood). 2003;Suppl Web Exclusives:W3-120-123.
11. Gilbody S, Wilson P, Watt I. Benefits and harms of direct to consumer advertising: a systematic review. Qual Saf Health Care. 2005;14:246-250.
12. Hollon MF, Larson EB, Koepsell TD, Downer AE. Direct-to-consumer marketing of osteoporosis drugs and bone densitometry. Ann Pharmacother. 2003;37:976-981.
13. Jeffords JM. Direct-to-consumer drug advertising: you get what you pay for. Health Aff (Millwood). 2004;Suppl Web Exclusives:W4-253-255.
14. Kelly P. DTC advertising's benefits far outweigh its imperfections. Health Aff (Millwood). 2004;Suppl Web Exclusives:W4-246-248.
15. Kravitz RL, Epstein RM, Feldman MD, Franz CE, Azari R, Wilkes MS, Hinton L, Franks P. Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial. JAMA. 2005;293:1995-2002.
16. Labovitch RS, Bozic KJ, Hansen E. An evaluation of information available on the internet regarding minimally invasive hip arthroplasty. J Arthroplasty. 2006;21:1-5.
17. Ling DC, Berndt ER, Kyle MK. Deregulating direct-to-consumer marketing of prescription drugs: effects on prescription and over-the-counter product sales. J Law Econ. 2002;45:691-723.
18. Lyles A. Direct marketing of pharmaceuticals to consumers. Annu Rev Public Health. 2002;23:73-91.
19. Meade-D'Alisera P, Merriweather T, Wentland M. Impact of commercial marketing on patient demand. Urol Nurs. 2001;21:406-407, 410.
20. Mintzes B, Barer ML, Kravitz RL, Bassett K, Lexchin J, Kazanjian A, Evans RG, Pan R, Marion SA. How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA. CMAJ. 2003;169:405-412.
21. Murray E, Lo B, Pollack L, Donelan K, Lee K. Direct-to-consumer advertising: physicians' views of its effects on quality of care and the doctor-patient relationship. J Am Board Fam Pract. 2003;16:513-524.
22. Prescription Drugs. FDA Oversight of Direct-to-Consumer Advertising Has Limitations. Washington, DC: United States General Accounting Office; 2002. Publication GAO-03-177.
23. Robinson AR, Hohmann KB, Rifkin JI, Topp D, Gilroy CM, Pickard JA, Anderson RJ. Direct-to-consumer pharmaceutical advertising: physician and public opinion and potential effects on the physician-patient relationship. Arch Intern Med. 2004;164:427-432.
24. Rosenthal MB, Berndt ER, Donohue JM, Frank RG, Epstein AM. Promotion of prescription drugs to consumers. N Engl J Med. 2002;346:498-505.
25. Schaffer JL, Krishnamuthi L, Ying X. Minimally invasive total joint arthroplasty and direct-to-consumer advertising. In: Hozack WJ, Krismer M, Nogler M, Bonutti PM, Rachbauer F, Schaffer JL, Donnelly WJ, eds. Minimally Invasive Total Joint Arthroplasty. Heidelberg: Springer; 2004:309-317.
26. Spence MM, Teleki SS, Cheetham TC, Schweitzer SO, Millares M. Direct-to-consumer advertising of COX-2 inhibitors: effect on appropriateness of prescribing. Med Care Res Rev. 2005;62:544-559.
27. Terzian TV. Direct-to-consumer prescription drug advertising. Am J Law Med. 1999;25:149-167.
28. Understanding the Effects of Direct-to-Consumer Prescription Drug Advertising. Menlo Park, CA: Henry J. Kaiser Family Foundation; 2001. Publication 3197.
29. Waxman HA. Ensuring that consumers receive appropriate information from drug ads: what is the FDA's role? Health Aff (Millwood). 2004;Suppl Web Exclusives:W4-256-258.
30. Weissman JS, Blumenthal D, Silk AJ, Newman M, Zapert K, Leitman R, Feibelmann S. Physicians report on patient encounters involving direct-to-consumer advertising. Health Aff (Millwood). 2004;Suppl Web Exclusives:W4-219-233.
31. Weissman JS, Blumenthal D, Silk AJ, Zapert K, Newman M, Leitman R. Consumers' reports on the health effects of direct-to-consumer drug advertising. Health Aff (Millwood). 2003;Suppl Web Exclusives:W3-82-95.
32. Wilkes MS, Bell RA, Kravitz RL. Direct-to-consumer prescription drug advertising: trends, impact, and implications. Health Aff (Millwood). 2000;19:110-128.
33. Woloshin S, Schwartz LM, Tremmel J, Welch HG. Direct-to-consumer advertisements for prescription drugs: what are Americans being sold? Lancet. 2001;358:1141-1146.
34. Woloshin S, Schwartz LM, Welch HG. The value of benefit data in direct-to-consumer drug ads. Health Aff (Millwood). 2004;Suppl Web Exclusives:W4-234-245.
35. Zachry WM 3rd, Dalen JE, Jackson TR. Clinicians' responses to direct-to-consumer advertising of prescription medications. Arch Intern Med. 2003;163:1808-1812.